Literature DB >> 21975038

Versatility of PRMT5-induced methylation in growth control and development.

Vrajesh Karkhanis1, Yu-Jie Hu, Robert A Baiocchi, Anthony N Imbalzano, Saïd Sif.   

Abstract

Arginine methylation governs important cellular processes that impact growth and proliferation, as well as differentiation and development. Through their ability to catalyze symmetric or asymmetric methylation of histone and non-histone proteins, members of the protein arginine methyltransferase (PRMT) family regulate chromatin structure and expression of a wide spectrum of target genes. Unlike other PRMTs, PRMT5 works in concert with a variety of cellular proteins including ATP-dependent chromatin remodelers and co-repressors to induce epigenetic silencing. Recent work also implicates PRMT5 in the control of growth-promoting and pro-survival pathways, which demonstrates its versatility as an enzyme involved in both epigenetic regulation of anti-cancer target genes and organelle biogenesis. These studies not only provide insight into the molecular mechanisms by which PRMT5 contributes to growth control, but also justify therapeutic targeting of PRMT5.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21975038      PMCID: PMC3225484          DOI: 10.1016/j.tibs.2011.09.001

Source DB:  PubMed          Journal:  Trends Biochem Sci        ISSN: 0968-0004            Impact factor:   13.807


  70 in total

1.  Brief report: combined chemical treatment enables Oct4-induced reprogramming from mouse embryonic fibroblasts.

Authors:  Xu Yuan; Haifeng Wan; Xiaoyang Zhao; Saiyong Zhu; Qi Zhou; Sheng Ding
Journal:  Stem Cells       Date:  2011-03       Impact factor: 6.277

2.  Protein arginine methyltransferase 5 accelerates tumor growth by arginine methylation of the tumor suppressor programmed cell death 4.

Authors:  Matthew A Powers; Marta M Fay; Rachel E Factor; Alana L Welm; Katharine S Ullman
Journal:  Cancer Res       Date:  2011-06-23       Impact factor: 12.701

3.  PRMT5 regulates Golgi apparatus structure through methylation of the golgin GM130.

Authors:  Zhongwei Zhou; Xiaotian Sun; Zhenhua Zou; Litao Sun; Tao Zhang; Shaoshi Guo; Ya Wen; Lin Liu; Yi Wang; Jun Qin; Lei Li; Weimin Gong; Shilai Bao
Journal:  Cell Res       Date:  2010-04-27       Impact factor: 25.617

Review 4.  Advances in the understanding of haemoglobin switching.

Authors:  Vijay G Sankaran; Jian Xu; Stuart H Orkin
Journal:  Br J Haematol       Date:  2010-03-01       Impact factor: 6.998

5.  Methylation of ribosomal protein S10 by protein-arginine methyltransferase 5 regulates ribosome biogenesis.

Authors:  Jinqi Ren; Yaqing Wang; Yuheng Liang; Yongqing Zhang; Shilai Bao; Zhiheng Xu
Journal:  J Biol Chem       Date:  2010-02-16       Impact factor: 5.157

6.  Identification of a PRMT5-dependent repressor complex linked to silencing of human fetal globin gene expression.

Authors:  Gerhard Rank; Loretta Cerruti; Richard J Simpson; Robert L Moritz; Stephen M Jane; Quan Zhao
Journal:  Blood       Date:  2010-05-21       Impact factor: 22.113

7.  Nuclear cyclin D1/CDK4 kinase regulates CUL4 expression and triggers neoplastic growth via activation of the PRMT5 methyltransferase.

Authors:  Priya Aggarwal; Laura Pontano Vaites; Jong Kyong Kim; Hestia Mellert; Buddha Gurung; Hiroshi Nakagawa; Meenhard Herlyn; Xianxin Hua; Anil K Rustgi; Steven B McMahon; J Alan Diehl
Journal:  Cancer Cell       Date:  2010-10-19       Impact factor: 31.743

8.  A germ cell-specific gene, Prmt5, works in somatic cell reprogramming.

Authors:  Go Nagamatsu; Takeo Kosaka; Miyuri Kawasumi; Taisuke Kinoshita; Keiyo Takubo; Hideo Akiyama; Tetsuo Sudo; Takashi Kobayashi; Mototsugu Oya; Toshio Suda
Journal:  J Biol Chem       Date:  2011-01-26       Impact factor: 5.157

9.  The expression of myogenic microRNAs indirectly requires protein arginine methyltransferase (Prmt)5 but directly requires Prmt4.

Authors:  Chandrashekara Mallappa; Yu-Jie Hu; Priscilla Shamulailatpam; Sookil Tae; Saïd Sif; Anthony N Imbalzano
Journal:  Nucleic Acids Res       Date:  2010-10-14       Impact factor: 16.971

10.  PRMT5 is required for cell-cycle progression and p53 tumor suppressor function.

Authors:  A Scoumanne; J Zhang; X Chen
Journal:  Nucleic Acids Res       Date:  2009-06-15       Impact factor: 16.971

View more
  110 in total

1.  PRMT5-Selective Inhibitors Suppress Inflammatory T Cell Responses and Experimental Autoimmune Encephalomyelitis.

Authors:  Lindsay M Webb; Stephanie A Amici; Kyle A Jablonski; Himanshu Savardekar; Amanda R Panfil; Linsen Li; Wei Zhou; Kevin Peine; Vrajesh Karkhanis; Eric M Bachelder; Kristy M Ainslie; Patrick L Green; Chenglong Li; Robert A Baiocchi; Mireia Guerau-de-Arellano
Journal:  J Immunol       Date:  2017-01-13       Impact factor: 5.422

Review 2.  The PRMT5 arginine methyltransferase: many roles in development, cancer and beyond.

Authors:  Nicole Stopa; Jocelyn E Krebs; David Shechter
Journal:  Cell Mol Life Sci       Date:  2015-02-07       Impact factor: 9.261

Review 3.  Transcriptional and Epigenomic Regulation of Adipogenesis.

Authors:  Ji-Eun Lee; Hannah Schmidt; Binbin Lai; Kai Ge
Journal:  Mol Cell Biol       Date:  2019-05-14       Impact factor: 4.272

4.  MTAP deletion confers enhanced dependency on the PRMT5 arginine methyltransferase in cancer cells.

Authors:  Gregory V Kryukov; Frederick H Wilson; Jason R Ruth; Joshiawa Paulk; Aviad Tsherniak; Sara E Marlow; Francisca Vazquez; Barbara A Weir; Mark E Fitzgerald; Minoru Tanaka; Craig M Bielski; Justin M Scott; Courtney Dennis; Glenn S Cowley; Jesse S Boehm; David E Root; Todd R Golub; Clary B Clish; James E Bradner; William C Hahn; Levi A Garraway
Journal:  Science       Date:  2016-02-11       Impact factor: 47.728

Review 5.  Protein arginine methylation: from enigmatic functions to therapeutic targeting.

Authors:  Qin Wu; Matthieu Schapira; Cheryl H Arrowsmith; Dalia Barsyte-Lovejoy
Journal:  Nat Rev Drug Discov       Date:  2021-03-19       Impact factor: 84.694

6.  Protein arginine methyltransferase 5 (PRMT5) promotes survival of lymphoma cells via activation of WNT/β-catenin and AKT/GSK3β proliferative signaling.

Authors:  Jihyun Chung; Vrajesh Karkhanis; Robert A Baiocchi; Saïd Sif
Journal:  J Biol Chem       Date:  2019-03-18       Impact factor: 5.157

7.  LLY-283, a Potent and Selective Inhibitor of Arginine Methyltransferase 5, PRMT5, with Antitumor Activity.

Authors:  Zahid Q Bonday; Guillermo S Cortez; Michael J Grogan; Stephen Antonysamy; Ken Weichert; Wayne P Bocchinfuso; Fengling Li; Steven Kennedy; Binghui Li; Mary M Mader; Cheryl H Arrowsmith; Peter J Brown; Mohammad S Eram; Magdalena M Szewczyk; Dalia Barsyte-Lovejoy; Masoud Vedadi; Ernesto Guccione; Robert M Campbell
Journal:  ACS Med Chem Lett       Date:  2018-04-23       Impact factor: 4.345

8.  A selective inhibitor of PRMT5 with in vivo and in vitro potency in MCL models.

Authors:  Elayne Chan-Penebre; Kristy G Kuplast; Christina R Majer; P Ann Boriack-Sjodin; Tim J Wigle; L Danielle Johnston; Nathalie Rioux; Michael J Munchhof; Lei Jin; Suzanne L Jacques; Kip A West; Trupti Lingaraj; Kimberly Stickland; Scott A Ribich; Alejandra Raimondi; Margaret Porter Scott; Nigel J Waters; Roy M Pollock; Jesse J Smith; Olena Barbash; Melissa Pappalardi; Thau F Ho; Kelvin Nurse; Khyati P Oza; Kathleen T Gallagher; Ryan Kruger; Mikel P Moyer; Robert A Copeland; Richard Chesworth; Kenneth W Duncan
Journal:  Nat Chem Biol       Date:  2015-04-27       Impact factor: 15.040

9.  Protein arginine methyltransferase 5 promotes cholesterol biosynthesis-mediated Th17 responses and autoimmunity.

Authors:  Lindsay M Webb; Shouvonik Sengupta; Claudia Edell; Zayda L Piedra-Quintero; Stephanie A Amici; Janiret Narvaez Miranda; Makenzie Bevins; Austin Kennemer; Georgios Laliotis; Philip N Tsichlis; Mireia Guerau-de-Arellano
Journal:  J Clin Invest       Date:  2020-04-01       Impact factor: 14.808

10.  The E3 ubiquitin ligase CHIP mediates ubiquitination and proteasomal degradation of PRMT5.

Authors:  Huan-Tian Zhang; Ling-Fei Zeng; Qing-Yu He; W Andy Tao; Zhen-Gang Zha; Chang-Deng Hu
Journal:  Biochim Biophys Acta       Date:  2015-12-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.